Viewing Study NCT06657053



Ignite Creation Date: 2024-10-25 @ 8:03 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06657053
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-10-22

Brief Title: Risk Factors of Epistaxis Recurrence in Adults
Sponsor: None
Organization: None

Study Overview

Official Title: Facteurs De Risques De Récidive Dépistaxis Chez Ladulte
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FREA
Brief Summary: We study all patients admitted to the Emergency Department in the Institution between 012022 and 072023 The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information Thus several potentiel risk factors were studied

The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test
Detailed Description: We study all patients admitted to the Emergency Department in the Institution between 012022 and 072023 The information about the recurrence of nose bleeding was searched on their medical file and by calling the patient to confirm ou get the information Thus several potentiel risk factors were studied oral anticoagulants sex INR anti-platelets drugs diabetes obesity arterial hypertension heart failure hemoglobin at the admission history of chronic rhinosinusitis appointment with an ENT during the acute bleeding sleep apnea age anatomic abnormality recent surgery within 2 months previous admission within 30 days in the emergency department nasal trauma

The relation between recurrence and those factors were studied at first individually and then all the significant ones were analyzed with a multivarious statistical test

This study aim to provide a pronostic score of recurrence that can happen after the 3 fisrt weeks after the event When a recurrence happens before 3 weeks this was considered to be a non control of the bleeding episode

This score will be then tested on our cohort to evaluate specificity and sensibility

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None